4//SEC Filing
Sherman Darren 4
Accession 0001104659-24-098693
CIK 0001814114other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 7:45 PM ET
Size
7.8 KB
Accession
0001104659-24-098693
Insider Transaction Report
Form 4
Sherman Darren
DirectorSee Remarks
Transactions
- Sale
Common Stock
2024-09-10$5.31/sh−6,904$36,660→ 765,787 total - Sale
Common Stock, par value $0.0001 per share ("Common Stock")
2024-09-09$5.48/sh−6,804$37,286→ 772,691 total
Footnotes (3)
- [F1]The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
- [F2]The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.57, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission (the "SEC"), the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.13 to $5.69, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001723524
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 7:45 PM ET
- Size
- 7.8 KB